Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Not fully characterized; depends on delivery method
Delivery
Topical application via hydrogel patches or transdermal formulations
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
PTD-DBM is a cell-penetrating peptide designed to inhibit CXXC5, a negative regulator of Wnt/β-catenin signaling. By blocking the interaction between CXXC5 and Dishevelled (Dvl), it promotes activation of Wnt pathways critical for hair follicle regeneration and wound healing. This peptide has shown promise in preclinical research for treating androgenetic alopecia and enhancing tissue repair.
Typically applied topically in research settings via hydrogel patches or other delivery systems. Experimental protocols have used combination therapy approaches with controlled-release formulations. Dosing and frequency vary by delivery method and remain under investigation in clinical trials.
PTD-DBM contains a protein transduction domain (PTD) fused to a Dishevelled-binding motif (DBM) that competitively inhibits CXXC5 binding to Dishevelled proteins. This inhibition prevents CXXC5 from suppressing Wnt/β-catenin signaling, thereby promoting dermal papilla cell proliferation, hair follicle neogenesis, and enhanced wound healing through reconstruction of the regenerative microenvironment.